Involvement of histone deacetylase 1/2 in adrenocorticotropic hormone synthesis and proliferation of corticotroph tumor AtT-20 cells

• Published in: Peptides (New York, N.Y. : 1980) Vol. 136; p. 170441
• Main Authors: Hagiwara, Rie, Kageyama, Kazunori, Niioka, Kanako, Takayasu, Shinobu, Tasso, Mizuki, Daimon, Makoto
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2021
• Subjects: Adrenocorticotropic hormone; Corticotroph tumor; Cushing’s disease; Histone deacetylase; Proopiomelanocortin; Histone deacetylase; Proopiomelanocortin; Adrenocorticotropic hormone; Corticotroph tumor; Cushing’s disease
• ISSN: 0196-9781; 1873-5169
• DOI: 10.1016/j.peptides.2020.170441

•Romidepsin treatment decreases ACTH synthesis in corticotroph tumor cells.•Romidepsin suppresses cell proliferation via PTTG1.•HDAC1 is involved in the proliferation of corticotroph cells via PTTG1. Cushing’s disease is mainly caused by autonomous production of adrenocorticotropic hormone (ACTH) from pituitary adenomas. In our previous study, a histone deacetylase (HDAC) inhibitor, trichostatin A, inhibited cell proliferation and ACTH production via decreased pituitary tumor-transforming gene 1 (PTTG1) in AtT-20 mouse corticotroph tumor cells. In the present study, we examined the effects of romidepsin, a potent and selective HDAC1/2 inhibitor, on cell proliferation and ACTH synthesis. To elucidate further potential mechanisms of romidepsin, we examined the effects of HDAC1/2 on proopiomelanocortin (Pomc) and Pttg1 mRNA levels and cell proliferation. Small interfering RNA-mediated knockdown was used to decrease HDAC1 or 2. Romidepsin treatment decreased Pomc and Pttg1 mRNA levels, and cell proliferation. The drug also increased Hdac1 and decreased Hdac2 mRNA levels. Hdac1 knockdown decreased basal Pttg1 mRNA levels and cell proliferation, but not Pomc mRNA levels. Romidepsin treatment decreases ACTH synthesis in corticotroph tumor cells. Romidepsin suppresses cell proliferation via PTTG1. HDAC1 is also involved in the proliferation of corticotroph cells via PTTG1.